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and platelets of 260  109/L. Clotting was normal, with a PT
of 11 seconds and a PTT of 27 seconds. Urinary protein excre-
tion was 1.7 g/24 h with a measured creatinine clearance of
64 mL/min. Laboratory values were as follows: serum sodium,
136 mmol/L; potassium, 4.3 mmol/L; urea, 8.4 mmol/L; and
creatinine, 1.1 mg/dL (97 mol/L). Liver function tests were
within normal limits: AST, 32 U/L (normal, 5-45); alkaline
phosphatase, 230 U/L (normal, 70-330); and ALT, 24 U/L (nor-
mal, 5-40). Corrected calcium was normal at 8.5 mg/dL
(2.2 mmol/L; normal, 2.2-2.6 mmol/L) as was serum phosphate
at 1.2 mmol/L (normal, 0.7-1.4 mmol/L).
Immunologic studies revealed an elevated ASO titer of 1200
IU/mL (normal, 0-200); normal immunoglobulin concentra-
tions; depressed C3, 0.26 g/L (normal, 0.83 to 1.46); and border-
line low levels of C4 at 0.19 g/L (normal, 0.20 to 0.52); ANCA,
anti-GBM, ANA, and rheumatoid factor were negative. An
atypical infection screen was reported as follows: herpesvirusCASE PRESENTATION
16 IU; mycoplasma 16 IU; Coxiella, 8 IU; and Legionella
An 18-year-old white female student presented to Hope 8 IU. A throat swab sample taken on admission failed to grow
Hospital, Salford, England, two years ago with a four-week any organisms.
history of general malaise and weight gain. The illness started Ultrasonography demonstrated two kidneys, 11 cm and
with a seven-day episode of anorexia, sore throat, cervical 12 cm in length, with normal echotexture. A chest radiograph
lymphadenopathy, and pyrexia. The illness progressed over the reported a cardiothoracic ratio of 15/29 with bilateral promi-
next three weeks with the development of vomiting, diarrhea, nence of the upper lobe vasculature. The lung fields were other-
and headache. One week prior to admission, she noticed swelling wise clear. An electrocardiogram revealed sinus rhythm and
of her legs and abdomen; the swelling spread to her face, was otherwise unremarkable.
particularly the peri-orbital region. A 10 kg weight gain was The patient was treated with bumetanide, which resulted in
noted during the week prior to presentation. Her primary care a good diuresis. Her blood pressure declined to 145/88 mm Hg
physician noted her blood pressure to be 170/105 mm Hg, and with the onset of the diuresis. Renal biopsy performed on day
urinalysis disclosed 3 proteinuria and 2 hematuria. 5 revealed 11 glomeruli, none of which was sclerosed. All
None of the symptoms were referable to the urinary tract. showed a global increase in cells, and the inflammatory infil-
Her medical history was unremarkable apart from a right lower trate included polymorphonuclear leukocytes. There was no
lobe pneumonia two years previously. The patient was a non- tuft necrosis, and no crescents were seen. The tubules, intersti-
smoker and was taking no regular medications. tium, and blood vessels all appeared normal. Immunoperoxi-
On examination, the patient weighed 69 kg. She had peri- dase stains revealed heavy basement membrane and mesangial
orbital edema and pitting edema of both ankles. Her blood staining for C3 with some of the basement membrane staining
pressure was 160/100 mm Hg. Funduscopy was unremarkable. having a “hump”-like appearance. IgG stained only weakly.
No murmurs were audible on auscultation of the precordium, IgM, IgA, C1q, and fibrinogen were negative. Electron micros-
and the chest was free of rales and rhonchi. copy showed the presence of subepithelial humps; some suben-
The abdomen and oropharynx were normal. Dipstick urinal- dothelial and mesangial deposits were also present. The pattern
ysis revealed 3 protein and 2 blood. Microscopy of the was consistent with post-infectious endocapillary proliferative
urine confirmed the presence of hematuria with 100 red cells glomerulonephritis.
and 60 white cells/mm3. Red cell casts were present. Hemoglo- Fourteen days after presentation, the patient was seen in
bin was 13.2 g/dL, with a white blood cell count of 6.6  109/L the outpatient clinic. Her blood pressure was 130/80 mm Hg
and body weight was 55 kg. She had no peripheral edema;
diuretic therapy was discontinued. Dipstick urinalysis showed
1 protein and 1 blood. Serum creatinine was 1.22 mg/dLThe Nephrology Forum is funded in part by grants from Amgen, Incor-
porated; Merck & Co., Incorporated; and Dialysis Clinic, Incorporated. (108mol/L); creatinine clearance was measured at 55 mL/min.
Red cells were noted in the urine but no casts were visualized.
Key words: post-infectious glomerulonephritis, phagocytes, macrophages, C3 was 0.4 g/L; C4, 1.1 g/L. Virology was repeated with no
streptokinase, renal inflammation change in titer noted.
Three months after presentation, the patient was seen again. 2001 by the International Society of Nephrology
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Her blood pressure was 120/75 mm Hg and her body weight mechanisms for the persistence of glomerular hypercellu-
was 56 kg; serum creatinine, 0.9 mg/dL (77 mol/L); creatinine larity that predisposes to glomerular scarring. Neverthe-
clearance, 75 mL/min; and 24-hour urinary protein excretion
less, my approach is selective because it is impossible toless than 0.05 g/day. Urinalysis was clear of blood and protein.
cite all relevant primary studies. I need not review com-The C3 had returned to normal at 1.1 g/L and the C4 was
0.3 g/L. Six months later the patient remained well with no prehensively the immunopathogenesis of PSGN, because
alteration in weight, serum creatinine, or urinary protein excre- Nordstrand and colleagues masterfully covered the topic
tion. Both C3 and C4 were normal. Urinalysis was clear and in a 1999 article [5]. Indeed, since the data on cellular
blood pressure was 125/75 mm Hg. Creatinine clearance was
mechanisms mediating resolution of PSGN are so scanty,measured at 78 mL/min. The patient was discharged from fol-
I will illustrate key principles by reference to animallow-up.
model data on the resolution of nephritis induced by
formation of complement-fixing immune complexes in
DISCUSSION situ in the glomerulus. Such models are broadly compati-
Dr. John Savill (Professor of Medicine and Director ble with prevalent hypotheses on the immune mecha-
of the University of Edinburgh/Medical Research Council nisms triggering PSGN.
Centre for Inflammation Research, University of Edinburgh It is widely assumed that nephritogenic streptococcal
Medical School, Edinburgh, UK): Although post-strep- antigens such as streptokinase are deposited in glomer-
tococcal glomerulonephritis (PSGN) may not be the prob- uli, leading to complement activation, C3 deposition,
lem it once was in the developed world, this condition recruitment of immune cells, IgG deposition, and subse-
remains important because it provides fascinating insights quent exacerbation of local glomerular inflammation [5].
into the glomerular response to immune injury and be- Streptokinase, as everyone knows, has now entered the
cause it remains a significant cause of nephritis in the therapeutic armamentarium as a thrombolytic agent and,
developing world [1, 2]. The case exemplifies many of the when administered to pre-immune individuals, can elicit
clinical features widely considered to be typical of PSGN the formation of circulating immune complexes and con-
in a cooler climate (readers not expert in European sequent “serum sickness” [6]. As this represents a mecha-
weather patterns can be assured that Manchester and its nism by which immunity to streptococci can injure glo-
environs enjoy a climate that many people would con- meruli, I also will present relevant unpublished data from
sider very cool). Thus, initial development of a sore studies of experimental glomerular injury by deposition
throat of likely streptococcal origin, a delay of around of circulating immune complexes, studies previously re-
two weeks, subsequent onset of a nephritic illness with ported by Professor Guy Neild of University College
salt and water retention, glomerular hematuria, and sig- London Medical School [7].
nificant albuminuria with little impairment of excretory
Cell clearancerenal function all are characteristic of PSGN. Similarly,
it comes as no surprise that this patient had marked The established glomerular lesion of PSGN clearly
suppression of circulating C3 levels, deposition of C3 and poses a problem of cell clearance if the histologic abnor-
some immunoglobulin G in the glomeruli, infiltration malities are to resolve. The first problem is marked infil-
by neutrophils, and increases in the number of intrinsic tration with inflammatory myeloid leukocytes, mainly
glomerular cells; these findings also can be regarded as neutrophils and monocyte/macrophages. In the seminal
“typical.” studies by Hooke and colleagues, acute post-infectious
My discussion of this case will focus on what I regard cases of glomerulonephritis exhibited approximately 17
as the most important characteristic of PSGN—the pro- neutrophils and 18 monocytes per glomerular cross-sec-
pensity for apparently complete resolution of the clinical tion [8]. These data bolstered an earlier study by Ferrario
abnormalities and, presumptively, the histologic changes. et al, in which approximately 9 monocytes per glomerular
My discussion will focus on cellular mechanisms likely cross-section were observed in a set of patients with docu-
to mediate resolution of leukocyte infiltration and glo- mented PSGN [9]. Although some evidence suggests lo-
merular hypercellularity in PSGN, as the condition is an cal monocytic cell proliferation [10], the vast majority of
important exemplar of mechanisms that can promote these leukocytes are likely to have been recruited through
spontaneous resolution of glomerular inflammation in mechanisms including generation of chemoattractant
other forms of post-infectious glomerulonephritis, in IgA complement fragments and local secretion of chemo-
nephropathy, and in Henoch-Scho¨nlein purpura. Fur- kines [11]. For resolution to occur, these infiltrating leu-
thermore, similar mechanisms might mediate glomerular kocytes must be cleared.
repair after immunosuppressive/anti-inflammatory ther- Second, established PSGN not only exhibits dramatic
apy of systemic vasculitis and lupus nephritis. But I do evidence of glomerular cell proliferation [10] but also dis-
not presume that PSGN always resolves. In light of evi- plays obvious increases in the number of certain types of
dence that a minority of patients with PSGN progress to resident glomerular cells. For example, Ludwigsen and
Sørensen reported peak increases in glomerular endo-end-stage renal failure [1, 3, 4], we will consider potential
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thelial cell number to 97% above baseline (that is, a near those biopsied two to four weeks after onset of symptoms
[14]. Obviously, potent mechanisms must account fordoubling) and in mesangial cell number to 67% above
baseline [12]. The lineage-specific nature of the mito- clearance of leukocytes and excess resident glomerular
cells as PSGN resolves.genic factors locally released (or of the cellular response
to such factors) is emphasized by the lack of a significant Apoptosis (programmed cell death), the physiologic
mechanism for safe deletion of unwanted or excess cellsincrease in glomerular visceral epithelial cells [12]. How-
ever, more work is required to characterize the prolifera- [15, 16], is therefore an obvious candidate for returning
the glomerular cell complement to normal as PSGN re-tive factors operating in PSGN, although some data point
to involvement of glomerular cell mitogens defined in solves. Intensive study of the molecular “program” of
apoptosis over the last decade has achieved a remarkablyvitro [13]. Nevertheless, whatever the mechanisms respon-
sible for proliferation of glomerular mesangial and endo- complete characterization of the molecular mechanisms
that result in the classic morphologic changes of apo-thelial cells, resolution of PSGN clearly requires that the
glomerulus remodel and delete excess intrinsic cells. ptotic cell death [17]. These include condensation of cyto-
plasm and nuclear heterochromatin, cellular shrinkage
Cell kinetics with preservation of organelles and, in some cell lineages,
very active blebbing of the dying cell, a process thatInvestigation of inflammatory and resident cell kinet-
ics in single renal biopsies from patients with PSGN is sometimes leads to reduction in cell volume by the re-
lease of membrane-bound apoptotic bodies. A key eventpossible because the time of onset of the clinical abnor-
malities usually can be determined with some accuracy; is activation of cysteine proteases termed “caspases” (be-
cause they cleave a variety of target proteins at aspartatethus, data from a series of patients can be assessed ac-
cording to a time course of the disease. A study in Japa- residues), which are thought to disassemble the cell [18-
20]. By cleaving an inhibitor [21], caspases also activatenese patients, which employed immunohistochemical de-
tection of proliferating cell nuclear antigen (PCNA), an endonuclease that leads to typical internucleosomal
fragmentation of chromatin (so-called caspase-activatedemphasized that proliferation of glomerular endothelial
cells, mesangial cells, and macrophages was a short-lived DNAse). This event can be detected in tissues by the
TUNEL technique [22], which detects DNA cleaved byphenomenon detectable only during the first three weeks
or so of the nephritic illness, an excess of neutrophils endonucleases, although great care is required to avoid
artefactual DNA cleavage during tissue preparation.still being apparent once this proliferative phase was
complete [10]. Proliferation was most evident in glomer- Oda and colleagues reported greatly increased TUNEL
labeling in glomeruli in PSGN [10], thus reinforcing theular endothelial cells, which represented approximately
80% of proliferating glomerular cells in the first week candidacy of this programmed type of cell death in the
resolution process.of the illness [10]; this finding is consistent with the peak
in endothelial cell number (90% above baseline) re- We must recognize, however, that apoptosis is much
more than programmed cell death—it is a program forported during weeks one to three in an earlier study
of Danish patients [12]. Similarly, the later increase in swift and safe cell clearance. By contrast with accidental
cell death or necrosis, in which pro-inflammatory releasemesangial cell proliferation to about 50% of all prolifer-
ating cells in the second and third weeks of clinical illness of injurious cell contents is inevitable, apoptosis in vivo
almost invariably leads to recognition and rapid uptake[10] was also consistent with earlier data indicating sus-
tained increases in mesangial cell number (to 60% by phagocytes of intact, membrane-bound apoptotic cells
or bodies [16, 23]. In many tissues, this clearance job isabove baseline) between the fourth and eighth week of
illness [12]. Finally, low-grade macrophage proliferation, carried out by healthy neighbors acting as “semi-profes-
sional” phagocytes, but where large numbers of apoptoticwhich disappeared after the third week of illness, was
consistent with a Pan-American series of patients who cells must be removed, the clearance job is performed
by the professional scavengers of the body, macrophages.exhibited a peak in monocyte/macrophage number to
approximately 3 per 100 glomerular cells between two Phagocytic clearance of apoptotic cells in vivo is highly
efficient and remarkably rapid; various strands of evi-and four weeks [14].
Nevertheless, cessation in cell birth by mitosis cannot dence indicate that in most tissues it takes an hour or
less for dying cells to become recognizably apoptotic,of itself explain the clear and dramatic fall in expanded
populations of glomerular cells as PSGN resolves. Thus, be taken up by phagocytes, and be degraded beyond
histologic detection after ingestion [23].in the series of Danish patients I mentioned, glomerular
endothelial cell and mesangial cell numbers had returned
Clearance of glomerular leukocytesto normal by approximately 8 and 24 weeks, respectively
[12], whereas in the Pan-American series, macrophage Compelling evidence indicates that neutrophils and
their toxic granular contents injure glomeruli, but untilnumbers fell threefold when patients with disease of
longer than four weeks in duration were compared with recently it was widely assumed that the usual fate of neu-
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trophils recruited to inflamed sites was eventual disinte- clearance from glomeruli by apoptosis [33]. First, when
we followed the fate of infused radiolabeled syngeneicgration before clearance of cellular fragments by macro-
phages [24]. This view ran counter to classic microscopic neutrophils, we found that during resolution of glomeru-
lar injury, about two-thirds of recruited neutrophils meet-studies by Metchnikoff undertaken in the late 19th cen-
tury, in which he identified the fate of inflammatory, ex- ing their fate locally were no longer histologically detect-
able at 24 hours, presumably because they were rapidlytravasated neutrophils as uptake of intact cells by macro-
phages (the “big eaters” of the inflammatory response) degraded by phagocytes: 50% of detectable autoradio-
graphic foci representing neutrophils retained at 24 hours[25]. However, after nearly a century of neglect, Newman
and colleagues rejuvenated interest in Metchnikoff’s semi- were inside macrophages. We also concluded that about
three-quarters of neutrophils sequestered in the lumennal work with their observation that intact neutrophils
“aged” overnight in culture were recognized and in- of glomerular capillaries left the kidney to meet their
fate elsewhere; the methods employed did not allow usgested by macrophages [26]. Haslett discovered that the
change in aging neutrophil populations that led to their to track these neutrophils, but we had strong indications
that the neutrophils had returned to the circulating bloodprogressively increasing susceptibility to phagocytosis was
constitutive apoptosis (defined as a spontaneous program pool, possibly because apoptosis had resulted in loss of
adhesion to the glomerular capillary wall [33]. Neverthe-of death arising from within the cell itself) and that an
increasing proportion of neutrophils exhibited typical less, despite the clear inference that histologically detect-
able neutrophil apoptosis in glomeruli represents “the tipfeatures of apoptosis with increasing time in culture
[27, 28]. We demonstrated that apoptosis in aged neutro- of an iceberg,” an important preliminary study of post-
infectious glomerulonephritis by Szabolcs and colleaguesphils derived from blood or inflamed sites directed their
recognition by macrophages, including human inflam- (abstract; Szabolcs et al, J Am Soc Nephrol 5:844A, 1994)
revealed an average of about one apoptotic cell per glo-matory macrophages ex vivo [28]. Furthermore, evidence
clearly indicated that neutrophil apoptosis leads to clear- merular cross-section, 300-fold greater than the number
in control healthy glomeruli. Thus, it does indeed seemance by macrophages in aspirates of joint fluid from
patients with arthritis [28]. Indeed, subsequent work by likely that what we can now regard as the “normal” means
of deletion of inflammatory neutrophils—efficient clear-Cox and colleagues reinforced the importance of consti-
tutive granulocyte apoptosis leading to phagocytic re- ance by in-situ apoptosis—does operate in PSGN. Clearly,
further work will be required to confirm this importantmoval in a model of self-limited lung inflammation [29].
These data were supported by clinical studies on neo- hypothesis; the recent development of a mouse model of
nephritis consequent upon slow leakage of streptococcalnatal respiratory distress [30] and asthma [31].
Does neutrophil clearance by apoptosis play an impor- antigens from infected sites, a model based on subcutane-
ous implantation of a cage containing a streptococcaltant role in resolution of PSGN? Animal models of im-
mune-mediated glomerular injury suggest that it does. innoculum, is likely to be useful [34].
Is neutrophil deletion by apoptosis likely to promoteFirst, in nephrotoxic-globulin-induced nephritis in rats,
we found clear evidence of neutrophil apoptosis leading resolution of PSGN? Answering this question will not be
possible until we have experimental means by which toto clearance both by glomerular inflammatory macro-
phages and mesangial cells acting as semi-professional block selectively phagocytic clearance of apoptotic neu-
trophils in a good animal model of PSGN. But our dataphagocytes [32]. Second, in the ConA/anti-ConA model
of immune complex nephritis, in which brief accumula- do emphasize the injury-limiting potential of this means
of neutrophil deletion. In particular, in vitro studies re-tion of neutrophils is almost exclusively limited to the
lumen of glomerular capillaries and resolves in about 24 vealed that neither macrophages nor mesangial cells tak-
ing up apoptotic neutrophils released pro-inflammatoryhours, we found clear histologic evidence of neutrophil
apoptosis and phagocytosis of apoptotic neutrophils by mediators, such as eicosanoids [35] or chemokines [36].
Furthermore, elegant work in other laboratories has dem-intraluminal macrophages, especially where neutrophils
were “trapped” in thrombosed capillary loops [33]. Indeed, onstrated that deliberately activated macrophages receive
an important “anti-inflammatory” signal from ingestingthe ability of intraluminal macrophages to ingest apo-
ptotic cells has been beautifully demonstrated in pre- apoptotic cells, which results in marked inhibition of the
release of pro-inflammatory cytokines such as tumor ne-viously unpublished electron microscopic images from
Professor Guy Neild’s studies of glomerular vascular in- crosis factor ; this signal is mediated in part by autocrine/
paracrine effects of the anti-inflammatory cytokine trans-jury in rabbits with a model of serum sickness (Fig. 1)
[7]. Therefore, there is a prima facie case that neutrophil forming growth factor-1 (TGF-1) [37, 38]. Therefore,
deletion of neutrophils undergoing apoptosis via uptakedeletion by apoptosis could occur in PSGN.
Our work on ConA/anti-ConA nephritis in rats further by activated macrophages could be a key pro-resolution
event in self-limited inflammation such as PSGN.emphasized that histologic studies might markedly un-
derestimate the quantitative significance of neutrophil Although freshly isolated blood monocytes are suscep-
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Fig. 1. Intraglomerular clearance of apoptotic cells. Electron micrograph of glomerular capillary from rabbit with glomerular injury induced by
serum sickness/cyclosporine A [7]. Note intraluminal macrophage (m) that has ingested several dying cells; one ingested cell (arrow) has classic
nuclear condensation of apoptosis (From Professor Guy Neild; magnification 8000).
tible to apoptosis, maturation into macrophages coin- after recognition as apoptotic and ripe for removal. For
example, in our study of ConA/anti-ConA nephritis, oc-cides with development of resistance to many pro-apo-
ptotic stimuli. Nevertheless, important studies by Lan casional macrophages bearing radiolabeled foci (com-
patible with earlier uptake of dying neutrophils) wereand colleagues in a rat model of crescentic glomerulone-
phritis (crescents are, of course, observed in some cases observed in hilar lymph nodes [33]. Such observations
could have great significance for regulation of immuneof PSGN) not only emphasize the proliferative capacity
of extravasated cells of the monocyte lineage [39], but responses in glomeruli in view of recent evidence that
macrophage-like immature myeloid dendritic cells canalso demonstrate that monocyte/macrophages can un-
dergo apoptosis in situ [40]. This mode of elimination ingest apoptotic cells and present certain antigens de-
rived from the apoptotic “meal” via both major histo-therefore might operate in PSGN.
Careful studies of the fate of labeled macrophages also compatibility complex (MHC) class I and class II to
CD8 and CD4 T lymphocytes, respectively [43–45].have emphasized that, unlike neutrophils, emigration via
the lymphatic vessels is a major route for removal of This antigen presentation might promote tolerance
rather than incite ongoing immune responses [46].macrophages from inflamed sites [41]. Indeed, one of
the earliest descriptions of this phenomenon—which ur-
Clearance of resident glomerular cellsgently requires mechanistic characterization—was in
nephrotoxic nephritis [42]. It seems possible that the In PSGN, as in many other forms of glomerular injury,
ultimate fate of emigrating macrophages is to undergo mesangial cells adopt a myofibroblast-like phenotype,
apoptosis in draining lymph nodes, but this speculation expressing -smooth muscle actin [47]. Abundant evi-
requires formal testing. dence from experimental proliferative glomerulonephri-
Cells of the monocyte/macrophage lineage emigrating tis indicates that excess myofibroblast-like mesangial
cells are deleted from glomeruli by undergoing apoptosisfrom inflamed sites might carry with them intracellular
“parcels” of inflammatory cells that undergo degradation [48, 49], which leads, in the main, to phagocytosis by
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healthy neighbors [48]. Therefore it seems likely that Potential mechanisms for failed resolution
some of the TUNEL-positive apoptotic cells identifed Little is known about the mechanisms by which a small
in PSGN [10] represent mesangial cells, although double- proportion of PSGN patients progress to persistent glo-
staining for -smooth muscle actin would help confirm merular inflammation and scarring with eventual loss of
this possibility. renal function [1, 3, 4]. However, if apoptosis of infiltrat-
I recently reviewed the diverse stimuli that regulate ing leukocytes and excess resident cells plays an impor-
mesangial cell apoptosis in vitro [50], so I wish to concen- tant role in the resolution of PSGN, then derangements
trate here on the possible importance of activated macro- in cell clearance by apoptosis could be critical in promot-
ing the persistence of tissue injury [60]. First, failed clear-phages in directing mesangial cell clearance by apoptosis.
ance of leukocytes undergoing apoptosis results in sec-Mene´ and colleagues reported that activated cells of the
ondary necrosis of non-ingested apoptotic cells and leadsU937 macrophage line could induce “cytolysis” of mesan-
to direct tissue injury by noxious cell contents as well asgial cells upon co-culture [51]. Their work, together with
to indirect exacerbation of inflammatory injury due tothat of Lang on macrophage-directed developmental cell
stimulation of macrophage secretion of pro-inflamma-death [52, 53], prompted us to examine whether activated
tory mediators [27, 60]. Additionally, failure of macro-macrophages isolated from experimentally inflamed rat
phage clearance of apoptotic leukocytes bearing ingestedglomeruli could regulate mesangial cell fate in co-culture
(streptococcal) antigens might allow such cells to be takenexperiments. Such macrophages and lipopolysaccharide/
up by dendritic cells so that antigen is presented to T-cells,-interferon-activated bone-marrow-derived macrophages
setting up a persistent and potentially damaging immune(but not quiescent macrophages) induced both suppres-
response [46]. Although a number of cell surface recogni-sion of mitosis and a dramatic increase in apoptosis, with
tion mechanisms ensure that macrophages can safely in-the result that the mesangial cell population in co-culture
gest apoptotic cells [reviewed in 23 and 61], recent datawas reduced [54]. Experiments with inhibitors and macro-
suggest that lectin-like functions of C1q, the first compo-phages from relevant “knock-out” mice revealed that the nent of complement, are particularly important in bind-
“downsizing” effects on mesangial cells were mediated by ing apoptotic cells in glomeruli and “bridging” them to
products of macrophage-inducible nitric oxide synthase C1q receptors on glomerular phagocytes [62, 63]. Indeed,
(iNOS or NOS2) in concert with another factor likely since C1q “knockout” mice spontaneously develop a lu-
to be tumor necrosis factor- (TNF-). Our current hy- pus-like disorder with glomerulonephritis, as observed in
pothesis is that the macrophage “beats as it sweeps as C1q-deficient humans [63], exhibit an excess of apoptotic
it cleans” (Fig. 2). Thus, although activated macrophages cells in glomeruli consistent with diminished clearance
can trigger apoptosis in unwanted or damaged resident [63], and possess diminished capacity to clear labeled apo-
cells [52-54] and accelerate apoptosis in bystander leuko- ptotic cells administered to the more accessible inflamed
cytes [55], we speculate that when these cells ingest apo- peritoneum [64], one can hypothesize that diminished
ptotic cells, they are “deactivated” [38] or “reprogrammed” C1q-mediated clearance of apoptotic cells in PSGN leads
[56] to become “reparative” (for example, secreting the to persistent inflammatory injury, consequent upon leak-
repair cytokine TGF-1 [38]) and/or “emigratory” [33, 57]. age of leukocyte contents and dendritic cell presentation
Hints suggest that macrophage-directed mesangial cell of antigens derived from ingested apoptotic cells, and to
apoptosis operates in PSGN, but the data are tenuous increased risk of progression to scarring.
Second, progression to hypocellular scar also could en-and require careful examination. Nevertheless, Hooke
sue if clearance of excess resident cells by apoptosis wereand colleagues’ report of a relative dearth of glomerular
undesirably prolonged, as in the case of glomerular endo-macrophages in a small series of PSGN patients exhib-
thelial cell loss in progressive nephrotoxic nephritis initing mesangial hypercellularity with little neutrophil in-
rats [59]. Many possible stimuli could increase the role offiltration is intriguing [8].
unscheduled glomerular cell loss by apoptosis [reviewedIn his early work on glomeruli injured by serum sick-
in 50]. However, a unifying hypothesis is that failed clear-ness/cyclosporine A, Prof. Guy Neild encountered mi-
ance of apoptotic cells denies activated macrophages acroscopic evidence of glomerular endothelial cell apo-
crucially important anti-inflammatory signal (Fig. 2), soptosis (Fig. 3) [7]. Furthermore, Shimizu and coworkers
that they continue to trigger apoptosis in resident cells,obtained clear evidence of (undesirable) endothelial cell
with the result that excess glomerular endothelial andapoptosis in progression to scarring of glomerular injury
mesangial cells are lost and a hypocellular scar is formed.experimentally induced by nephrotoxic globulin [58, 59].
Indeed, Lang reported definitive evidence that macro-
CONCLUSIONSphages can dock onto and induce apoptosis in unwanted
microvascular endothelial cells in the developing rodent Post-streptococcal glomerulonephritis warrants contin-
eye [52, 53]. It therefore appears likely that studies of uing detailed investigation because defining mechanisms
glomerular endothelial cell apoptosis will yield new in- by which inflammation resolves will provide exciting new
insights into what goes wrong when glomerular inflam-sights into the resolution of PSGN.
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Fig. 2. Hypothesis for regulation of macrophage activation by interaction with apoptotic cells. Activated macrophages (Mø) can accelerate
leukocyte apoptosis and trigger resident cell apoptosis. Subsequent phagocytosis of the apoptotic progeny deactivates or “reprograms” the
macrophage, which then receives signals to promote, repair, and/or emigrate. Mø, macrophages.
mation persists and leads to scarring. Perhaps the most infected site and the subsequent development of immune
important insight is that disappearance of the original complex glomerulonephritis by putting a streptococcal
stimulus, streptococcal infection, might not be enough inoculum inside a cage implanted under the skin in ro-
to promote resolution. Although much more work needs dents [34]. This model might allow experimental studies
to be done to substantiate the role of apoptosis in resolu- of programmed cell death in this condition.
tion of this and other forms of nephritis, the discovery Dr. Madias: Would you speculate on the determinants
that this cell clearance program is involved generates of the variable severity of disease in post-streptococcal
new hypotheses for mechanisms promoting progression glomerulonephritis from sub-clinical to severe crescentic
to chronic renal failure. disease? What factors might mediate this spectrum?
Prof. Savill: Variable disease severity might reflect
differences in the initiation of the inflammatory response,QUESTIONS AND ANSWERS
differences in its regulation once established, or differ-Dr. Nicolaos E. Madias (Executive Academic Dean,
ences in its resolution, three processes that could overlapTufts University School of Medicine, Boston, Massachu-
in some types of inflammatory response. Multiple influ-setts): Has the development of the pathologic process in
ences might be expected to impinge on these processes,post-streptococcal glomerulonephritis been studied in
ranging from cytokine polymorphisms to levels of C1q [64].experimental models?
Dr. Madias: Can you tell us a bit more about the exitProf. Savill: Yes, Norstrand’s group has successfully
modeled slow leakage of streptococcal antigen from an of macrophages in the resolution phase?
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Fig. 3. Glomerular endothelial cell apoptosis. Electron micrograph of glomerular capillary from rabbit with glomerular injury induced by serum
sickness/cyclosporine A [7]. On the left (black arrow) an injured glomerular endothelial cell displays typical nuclear morphology of apoptosis. On
the right (white arrow) a neutrophil exhibits early apoptotic changes (From Professor Guy Neild; 2000).
Prof. Savill: As I mentioned, this issue was first exam- tre, Stoke on Trent, England): John, you touched briefly
on a fascinating topic—the mechanism of control of cellined in experimental nephritis by Atkins’ group, who
reported migration of macrophage-like cells from in- numbers within an organ. Is that mechanism related to
the glomerulus?flamed glomeruli to draining lymph nodes [42]. Subse-
quently Bellingan labeled macrophages in experimental Prof. Savill: No definitive data have determined what
governs how many cells should be in a glomerulus. Oneperitonitis and then tracked macrophage emigration, and
found that macrophages leave the peritoneum by migra- important influence is the macrophage [54], but we don’t
know where the computer lies that tells the macrophagestion into the lymphatics and passage to the draining
nodes, where it is speculated that they undergo apoptosis to regulate cell number. Another favored hypothesis is
that microvascular endothelial cells also have the ability[41]. The mechanisms controlling macrophage emigra-
tion from inflamed sites are poorly understood but will to govern cell number by determining oxygen supply [65].
Prof. John Feehally (Leicester General Hospital,be important to define.
Dr. Rodney Gilbert (Department of Paedriatrics, St. Leicester, England): I appreciated your response to Dr.
Madias about variations in initiation, regulation, andJames University Hospital, Leeds, England): There are
important differences in the outcomes in certain glomeru- resolution. Nevertheless, the disease we are discussing
is extraordinarily striking compared to any other humanlar diseases in children and adults. Post-streptococcal glo-
merulonephritis is an obvious example, and hepatitis glomerular disease for its intensity and its complete re-
covery. Why is it so different? Is it just because neutro-B-associated membranous nephropathy is another. Are
there differences in apoptosis and control of apoptosis in phils are so dominant in this disease and that they are
particularly susceptible to clearance? Or are other thingschildren and adults that might explain these discrepancies?
Prof. Savill: This would be an interesting area for going on?
Prof. Savill: Post-streptococcal glomerulonephritis isfuture studies.
Dr. Patrick Naish (North Staffordshire Hospital Cen- not merely influx of neutrophils, as there is a very typical
Nephrology Forum: Post-streptococcal glomerulonephritis 1211
inflammatory response in terms of resident cell prolifera- Your second question addressed the place of immuno-
suppressive or anti-inflammatory therapies in post-strep-tion. I think this is the glomerular equivalent of other
severe but self-limited inflammatory disorders such as tococcal nephritis. My bias would be to rely on the pow-
erful natural resolution processes unless renal functionpneumococcal pneumonia, which sometimes resolves
completely without antibiotics, and comparably severe declines or many crescents are present, in which case I
would advise immunosuppression, including glucocorti-inflammatory conditions in the skin or the bowel, which
also can resolve completely. I would speculate that this coids. In Edinburgh we have recently seen surprisingly
complete resolution upon follow-up biopsy after immu-propensity for resolution reflects the fact that post-strep-
tococcal glomerulonephritis and comparable conditions nosuppressive treatment of a patient with post-strepto-
coccal glomerulonephritis presenting with 100% cres-are examples of perfect elimination of a “one-shot” ini-
tiating stimulus by a classic, and therefore apparently cents, but we will never know whether the treatment
was necessary!severe, acute inflammatory response, which can then re-
solve completely with perfect “healing.” I suspect that Prof. Neil Turner (Royal Infirmary of Edinburgh):
You suggested that a difference between cases that re-the longevity of the initiating stimulus is one important
determinant of the outcome of glomerulonephritis, di- solve versus cases that progress to scarring is closely
related to the duration of the initiating stimulus. Yet youminished clearance of the stimulus by a suboptimal in-
flammatory response being a risk factor for persistence. also suggested that later scarring could be a problem
with the mechanism of apoptosis. Isn’t it more likely toHowever, you will have gathered that I believe that de-
fective resolution mechanisms should also be sought in be related to continuing injury or some problem with
the resident cells?types of nephritis that persist.
Dr. Michael Venning (University of South Manches- Prof. Savill: In fact, I favor a hypothesis subtly differ-
ent from those you mention, namely, that progression toter, South Manchester, England): I would be interested in
your comments about the analogous but different disease, scarring occurs because of dysregulated control of resi-
dent cell number by apoptosis, and that this dysregulatedproliferative nephritis associated with bacterial endocar-
ditis. We have sporadic and unpublished evidence sug- control is engendered by the persistence of cytocidal
macrophages. Although I cannot be sure on the basis ofgesting that vigorous intervention in this setting is bene-
ficial: first, valve replacement if it can be achieved, and the published data, I have the impression that progres-
sion to scarring can sometimes occur despite clinicalsecond, the use of steroids. In settings in which valve
replacement hasn’t been used and steroids have not been evidence of complete resolution of well-validated post-
streptococcal glomerulonephritis. Consequently, pro-administered, our feeling is that the disease grumbles on
and causes scarring. My first question is, what is your gression to scarring in this disorder might be one of the
best arguments against a prolonged initiating stimulusview about therapies in the setting of bacterial endocar-
ditis? Second, in patients with post-streptococcal nephri- being central to a bad outcome. It might be that elimina-
tion of the initiating stimulus is universal in post-strepto-tis whose disease doesn’t seem to be resolving, should
we be using therapeutic maneuvers to try and control coccal glomerulonephritis, but what might not be univer-
sal is complete resolution. I don’t really have time to gothe progression to scarring?
Prof. Savill: Those are very good questions, and both into a large number of experimental studies that suggest
that discrete events very early in an inflammatory re-are relevant to a related issue that I would like to address
first. Not only is there in vitro evidence [66], but we also sponse can govern subsequent events many days, weeks,
and years down the line. Nevertheless, I suspect that inhave preliminary in vivo evidence that high concentra-
tions of glucocorticoids drive noninflammatory phago- most cases of progressive nephritis, the injurious stimulus
is long gone and yet aspects of post-inflammatory remod-cyte clearance of apoptotic cells from inflamed sites
(Thomas G, Clay M, Savill J, unpublished data). How- eling such as macrophage-directed, resident cell apopto-
sis persist undesirably.ever, in the context of post-streptococcal glomerulone-
phritis, this potentially pro-resolution effect of glucocor- Dr. Paul Brenchly (Manchester Royal Infirmary,
Manchester, England): John, we know a lot about theticoids needs to be set against the potentially deleterious
effects of prolonging neutrophil lifespan [67]. cytokine growth factor profile that can activate macro-
phages to become more interested in removing cells byLet me return to your first question. My bias is that
judicious immunosuppression likely helps in infectious apoptosis, but what do we know about the cytokine pro-
file that might actually switch them out of that phase?disorders such as endocarditis with immunologic compli-
cations like nephritis. I would view these situations as Or is there a normal default pattern that, once macro-
phages find there aren’t any more apoptotic cells, theybeing analogous to ANCA-positive vasculitis, in which
relapse or exacerbation frequently is triggered by infec- naturally default to a more quiescent phase?
Prof. Savill: I’m not sure that we know enough abouttion, and one needs to both increase the immunosuppres-
sive therapy and treat the infection. factors that govern acquisition by monocytes of the abil-
Nephrology Forum: Post-streptococcal glomerulonephritis1212
ity for large-scale clearance of apoptotic cells as the those observations are? Second, if they are valid, do they
monocytes mature into macrophages, but I would like to provide us with any clues as to the genetic basis of some
emphasize that the act of eating apoptotic cells is a po- of these failures of resolution?
tent stimulus towards “quiescence,” as evidenced by de- Prof. Savill: These are two very important questions.
creased production of pro-inflammatory cytokines upon First, although I also have noticed that much of the
exposure to endotoxin [37, 38], suppression of antigen evidence that this disorder can “go bad” comes from
presentation by dendritic cells [43, 46], and our prelimi- studies undertaken in the developing world, where inves-
nary observation of macrophages’ diminished capacity tigation of patients like this, for obvious reasons, isn’t
to kill mesangial cells. It seems likely that all of these as fastidious as it might be in richer countries, I think that
phenomena of quiescence could reflect the autocrine/ there is well validated evidence that post-streptococcal
paracrine effects of TGF-1, which is released after up- glomerulonephritis can progress. Moving on to the sec-
take of apoptotic cells [38]. I speculate that activated ond part of your question, it would be of great interest
macrophages that fail to ingest apoptotic cells are denied to study such patients by modern molecular genetic tech-
an important “turn off” signal, so perhaps the default niques such as microarray expression profiling, using pa-
pattern is to remain injurious rather than become quies- tients whose disease did resolve properly as controls. As
cent or reparative.
I emphasized at the beginning, I think we can learn a
Dr. Brenchly: May I ask a second question? I was
lot about the pathogenesis of nephritis from patientsinterested to see the very potent endothelial cell prolifer-
with post-streptococcal nephritis.ation very early, and this case is a good example of
Dr. Philip Kalra (Hope Hospital, Manchester): Inglomerular endothelial proliferation. We don’t know,
patients with proliferative glomerular diseases that arebut I suspect that this proliferation might be driven by
more commonly associated with scarring and end-stagevascular endothelial growth factor (VEGF), and the neu-
renal failure, is there any evidence of disturbed controltrophil carries quite a load of VEGF. Would you see
of cell number by apoptosis within the tubulointerstitialthat as the main source of the endothelial mitogenesis?
compartment rather than in the glomerulus?Prof. Savill: That is an extremely interesting sugges-
Prof. Savill: That is a particularly apposite questiontion, which could be tested by neutrophil depletion in an
because, although I emphasized the classic observation ofanimal model, and supported by immunohistochemical
minimal histologic evidence of tubulointerstitial involve-studies in human cases.
ment in this case of post-streptococcal glomerulonephri-Prof. Jean-Pierre Gru¨nfeld (Hoˆpital Necker, Paris,
France): In recent years it has been shown that post- tis, sharp-eyed members of the audience will have seen
infectious or maybe infectious glomerulonephritis was that the beautiful studies by Oda and colleagues [10]
more prevalent and more severe in alcoholic patients. have demonstrated increased PCNA staining in the tubu-
Might this difference be related to a defect in apoptosis? lointerstitial compartment of such patients. This finding
Do we have any data on the relationship between alco- emphasizes the possible influence of changes in number
holism and apoptosis? of tubulointerstitial cells, even in such a “clean” glomeru-
Prof. Savill: You will be intrigued to hear that I have lar injury. There is growing evidence of unscheduled tubu-
the impression that my own neutrophils exhibit acceler- lointerstitial cell apoptosis in many forms of renal injury,
ated constitutive apoptosis after I have taken alcohol, but an experimental priority will be to show that modu-
but definitive studies are required! lating such apoptosis alters the outcome of renal injury.
Prof. Gru¨nfeld: My second question is very simple Dr. Rupert Smith (Birch Hill Hospital, Rochdale, Eng-
and naı¨ve. What is your opinion on the indication of land): As you say, post-streptococcal glomerulonephritis
renal biopsy in patients with typical post-streptococcal
is rare in Scotland and England, but most units see a lot
glomerulonephritis? Is it useful or not?
of Henoch-Scho¨nlein purpura, and we have to follow upProf. Savill: It probably isn’t useful in specific patient
those patients for long periods if they get hematuria. Imanagement other than for excluding severe crescentic
realize it is not the same disease, but are there any paral-change or another, unsuspected cause of severe glo-
lels with post-streptococcal glomerulonephritis in termsmerular injury, either of which might need heavy im-
of what is going on in the kidney?munosuppression. In the case presented today, I would
Prof. Savill: I would speculate that there are. I don’thave wanted to biopsy to ensure that I was not missing
know of any studies, histologic or otherwise, of the injuredan ANCA-negative vasculitis or some such condition.
kidney in Henoch-Scho¨nlein purpura with regard toDr. Donal O’Donoghue (Hope Hospital, Manchester):
whether there is cell clearance by apoptosis, but obviouslyI am interested in the epidemiology of post-streptococcal
the relationship to IgA nephropathy would encourageglomerulonephritis, in which quite a variability exists in
us to believe there are powerful resolution processes inthe number or percentage of patients who go on to de-
velop end-stage renal failure. How valid do you think operation in patients with Henoch-Scho¨nlein purpura.
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